UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2020-01, Vol.31 (1), p.17-29

2020

Volltextzugriff (PDF)

Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Annals of oncology, 2013-10, Vol.24 Suppl 6, p.vi144-vi148

2013

Volltextzugriff (PDF)

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT

Gut, 2011-06, Vol.60 (6), p.747-758

2011

Volltextzugriff (PDF)

Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?

Clinical oncology (Royal College of Radiologists (Great Britain)), 2023-03, Vol.35 (3), p.e256-e262

2023

Volltextzugriff (PDF)

T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

Leukemia, 2005-04, Vol.19 (4), p.652-658

2005

Volltextzugriff (PDF)

Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma

Leukemia, 2006-02, Vol.20 (2), p.313-318

2006

Volltextzugriff (PDF)

Palliative chemotherapy for advanced gastric cancer

Annals of oncology, 2004-11, Vol.15 (11), p.1585-1595

2004

Volltextzugriff (PDF)

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

International journal of endocrinology, 2020, Vol.2020 (2020), p.1-8

2020

Volltextzugriff (PDF)

Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29]

Annals of oncology, 2023-03, Vol.34 (3), p.325-325

2023

Volltextzugriff (PDF)

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial

Annals of oncology, 2015-08, Vol.26 (8), p.1760-1765

2015

Volltextzugriff (PDF)

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

Annals of oncology, 2023-09, Vol.34 (9), p.734-771

2023

Volltextzugriff (PDF)

CLinicopathological characteristics of extranodal marginal zone B‐cell lymphoma of the intestine: a single center analysis

Hematological oncology, 2023-06, Vol.41 (S2), p.394-394

2023

Volltextzugriff (PDF)

Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas

Gut, 2006-05, Vol.55 (5), p.616-618

2006

Volltextzugriff (PDF)

Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites

Leukemia, 2004-10, Vol.18 (10), p.1722-1726

2004

Volltextzugriff (PDF)

How I treat medullary thyroid cancer

ESMO open, 2021-06, Vol.6 (3), p.100183-100183, Article 100183

2021

Volltextzugriff (PDF)

Assessment of Helicobacter pylori (HP) negative gastric MALT lymphoma for non‐H.pylori Helicobacter using multiplex PCR: a retrospective analysis

Hematological oncology, 2023-06, Vol.41 (S2), p.294-294

2023

Volltextzugriff (PDF)

Corrigendum to ‘How I treat medullary thyroid cancer’: [ESMO Open Volume 6, Issue 3, June 2021, 100183]

ESMO open, 2022-06, Vol.7 (3), p.100516-100516, Article 100516

2022

Volltextzugriff (PDF)

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading

Annals of oncology, 2006-05, Vol.17 (5), p.780-784

2006

Volltextzugriff (PDF)

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Leukemia, 2017-05, Vol.31 (5), p.1117-1122

2017

Volltextzugriff (PDF)

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice

ESMO open, 2022-06, Vol.7 (3), p.100478-100478, Article 100478

2022

Volltextzugriff (PDF)

Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series

Gut, 2007-12, Vol.56 (12), p.1685-1687

2007

Volltextzugriff (PDF)

Differential expression of NF-[kappa]B target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism

Leukemia, 2010-08, Vol.24 (8), p.1487-1497

2010

Volltextzugriff (PDF)

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

Epidemiology and psychiatric sciences, 2022-01, Vol.31, p.e74-e74, Article e74

2022

Volltextzugriff (PDF)

DEPTH OF REMISSION FOLLOWING FIRST LINE HP‐ERADICATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN GASTRIC MALT LYMPHOMA

Hematological oncology, 2019-06, Vol.37 (S2), p.263-263

2019

Volltextzugriff (PDF)

Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)

Annals of oncology, 2018-10, Vol.29, p.viii467-viii468

2018

Volltextzugriff (PDF)

1 – 25 von 420

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(391)
Mit Volltextzugriff
(365)

Publikationsform

Sprache

Englisch
(397)
Deutsch
(27)

Erscheinungsjahr

n.n

Thema

Humans
(242)
Science & Technology
(234)
Life Sciences & Biomedicine
(232)
Female
(158)
Biological And Medical Sciences
(156)
Medical Sciences
(153)
Male
(152)
Middle Aged
(148)
Oncology
(142)
Aged
(138)
Adult
(104)
Chemotherapy
(76)
Treatment Outcome
(68)
Pharmacology. Drug Treatments
(67)
Antineoplastic Agents
(56)
Aged, 80 And Over
(52)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(51)
Hematologic And Hematopoietic Diseases
(46)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(46)
Tumors
(46)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Gastric marginal zone lymphoma of MALT type: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

EGILS consensus report. Gastric extranodal marginal zone B-cell lymphoma of MALT

Localised Synovial Sarcoma in Adolescents and Young Adults Versus Adults – Is There a Difference in Outcome?

T(3;14)(p14.1;q32) involving IGH and FOXP1 is a novel recurrent chromosomal aberration in MALT lymphoma

Novel t(5;9)(q33;q22) fuses ITK to SYK in unspecified peripheral T-cell lymphoma

Palliative chemotherapy for advanced gastric cancer

Real-World Data for Lenvatinib in Radioiodine-Refractory Differentiated Thyroid Cancer (RELEVANT): A Retrospective Multicentric Analysis of Clinical Practice in Austria

Corrigendum to “Marginal zone lymphomas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 31 (2020) 17–29]

High-dose clarithromycin is an active monotherapy for patients with relapsed/refractory extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue (MALT): the HD-K phase II trial

ESMO-Magnitude of Clinical Benefit Scale for haematological malignancies (ESMO-MCBS:H) version 1.0

CLinicopathological characteristics of extranodal marginal zone B‐cell lymphoma of the intestine: a single center analysis

Successful antibiotic treatment of Helicobacter pylori negative gastric mucosa associated lymphoid tissue lymphomas

Variable frequencies of MALT lymphoma-associated genetic aberrations in MALT lymphomas of different sites

How I treat medullary thyroid cancer

Assessment of Helicobacter pylori (HP) negative gastric MALT lymphoma for non‐H.pylori Helicobacter using multiplex PCR: a retrospective analysis

Corrigendum to ‘How I treat medullary thyroid cancer’: [ESMO Open Volume 6, Issue 3, June 2021, 100183]

18F-fluoro-deoxy-glucose positron emission tomography (18F-FDG-PET) visualizes follicular lymphoma irrespective of grading

Ristocetin-induced platelet aggregation for monitoring of bleeding tendency in CLL treated with ibrutinib

Pulmonary neuroendocrine tumours and somatostatin receptor status: an assessment of unlicensed use of somatostatin analogues in the clinical practice

Most patients with minimal histological residuals of gastric MALT lymphoma after successful eradication of Helicobacter pylori can be managed safely by a watch and wait strategy: experience from a large international series

Differential expression of NF-[kappa]B target genes in MALT lymphoma with and without chromosome translocation: insights into molecular mechanism

Prevalence of anxiety and depression in people with different types of cancer or haematologic malignancies: a cross-sectional study

DEPTH OF REMISSION FOLLOWING FIRST LINE HP‐ERADICATION IS AN INDEPENDENT PROGNOSTIC FACTOR IN GASTRIC MALT LYMPHOMA

Activity & safety of spartalizumab (PDR001) in patients (pts) with advanced neuroendocrine tumors (NET) of pancreatic (Pan), gastrointestinal (GI), or thoracic (T) origin, & gastroenteropancreatic neuroendocrine carcinoma (GEP NEC) who have progressed on prior treatment (Tx)

Suchergebnisse filtern